DK0697887T3 - Stabile flydende gamma-interferonholdige præparater - Google Patents

Stabile flydende gamma-interferonholdige præparater

Info

Publication number
DK0697887T3
DK0697887T3 DK94916004T DK94916004T DK0697887T3 DK 0697887 T3 DK0697887 T3 DK 0697887T3 DK 94916004 T DK94916004 T DK 94916004T DK 94916004 T DK94916004 T DK 94916004T DK 0697887 T3 DK0697887 T3 DK 0697887T3
Authority
DK
Denmark
Prior art keywords
stable liquid
gamma interferon
gamma
containing preparations
ifn
Prior art date
Application number
DK94916004T
Other languages
English (en)
Inventor
Tue Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0697887T3 publication Critical patent/DK0697887T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
DK94916004T 1993-05-12 1994-05-04 Stabile flydende gamma-interferonholdige præparater DK0697887T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6032793A 1993-05-12 1993-05-12
PCT/US1994/004928 WO1994026302A1 (en) 1993-05-12 1994-05-04 Stable liquid compositions of gamma interferon

Publications (1)

Publication Number Publication Date
DK0697887T3 true DK0697887T3 (da) 1999-08-09

Family

ID=22028807

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916004T DK0697887T3 (da) 1993-05-12 1994-05-04 Stabile flydende gamma-interferonholdige præparater

Country Status (23)

Country Link
EP (1) EP0697887B1 (da)
JP (1) JP4053586B2 (da)
KR (1) KR100330325B1 (da)
CN (1) CN1120724C (da)
AT (1) ATE173632T1 (da)
AU (1) AU683469B2 (da)
CA (1) CA2159602C (da)
CZ (1) CZ285389B6 (da)
DE (1) DE69414841T2 (da)
DK (1) DK0697887T3 (da)
ES (1) ES2126114T3 (da)
FI (1) FI111442B (da)
GR (1) GR3029286T3 (da)
HK (1) HK1008303A1 (da)
HU (1) HUT72980A (da)
IL (1) IL109350A (da)
NO (1) NO320069B1 (da)
NZ (1) NZ266354A (da)
PL (1) PL176079B1 (da)
SK (1) SK280958B6 (da)
TW (1) TW275585B (da)
WO (1) WO1994026302A1 (da)
ZA (1) ZA942955B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2758154B2 (ja) * 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
DK0862452T3 (da) * 1995-11-07 2004-04-05 Genentech Inc Stabiliserende formulering af NGF
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
JP3493866B2 (ja) * 1995-12-27 2004-02-03 ライオン株式会社 発泡性口腔用組成物
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
AU729415B2 (en) 1996-07-12 2001-02-01 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
PT948358E (pt) * 1996-12-24 2004-10-29 Biogen Idec Inc Formulacoes de interferao liquidas e estaveis
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US7070799B1 (en) 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
WO2001072278A2 (en) * 2000-03-30 2001-10-04 Generex Pharmaceuticals Inc. Method for administering insulin to the buccal region
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
EP1391209A4 (en) * 2001-05-30 2009-12-16 Chugai Pharmaceutical Co Ltd PROTEIN PREPARATION
EP1516627A1 (en) * 2003-09-17 2005-03-23 CONARIS research institute AG Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
JP5137055B2 (ja) * 2006-03-10 2013-02-06 塩野義製薬株式会社 安定化されたインターフェロン−γ組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779221D1 (de) * 1986-08-19 1992-06-25 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation

Also Published As

Publication number Publication date
NO954544D0 (no) 1995-11-10
ZA942955B (en) 1995-10-30
NO320069B1 (no) 2005-10-17
NZ266354A (en) 1997-06-24
AU683469B2 (en) 1997-11-13
CZ285389B6 (cs) 1999-07-14
WO1994026302A1 (en) 1994-11-24
JPH08510242A (ja) 1996-10-29
KR100330325B1 (ko) 2002-11-01
CA2159602A1 (en) 1994-11-24
TW275585B (da) 1996-05-11
EP0697887A1 (en) 1996-02-28
HK1008303A1 (en) 1999-05-07
FI955136A0 (fi) 1995-10-27
ES2126114T3 (es) 1999-03-16
EP0697887B1 (en) 1998-11-25
CN1120724C (zh) 2003-09-10
HUT72980A (en) 1996-06-28
DE69414841T2 (de) 1999-06-02
NO954544L (no) 1995-11-10
CA2159602C (en) 2008-08-26
FI955136A (fi) 1995-10-27
IL109350A0 (en) 1994-07-31
SK137895A3 (en) 1997-02-05
CN1122575A (zh) 1996-05-15
PL311639A1 (en) 1996-03-04
DE69414841D1 (de) 1999-01-07
JP4053586B2 (ja) 2008-02-27
SK280958B6 (sk) 2000-10-09
CZ295595A3 (en) 1996-04-17
ATE173632T1 (de) 1998-12-15
KR960702320A (ko) 1996-04-27
HU9503223D0 (en) 1996-01-29
IL109350A (en) 2001-01-28
FI111442B (fi) 2003-07-31
GR3029286T3 (en) 1999-05-28
AU6782294A (en) 1994-12-12
PL176079B1 (pl) 1999-04-30

Similar Documents

Publication Publication Date Title
DK0697887T3 (da) Stabile flydende gamma-interferonholdige præparater
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
IL103510A0 (en) Pharmaceutical compositions containing antibodies for causing immunosuppression
HU9203871D0 (en) Pharmaceutical application of certain cistine derivatives
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
DE69420872D1 (de) Hgh enthaltende pharmazeutische zubereitungen
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
DK0972521T3 (da) Farmaceutisk præparat, der indeholder interferon-gamma-stimulatorer
IT8124897A0 (it) Composizione farmaceutica per la terapia di calcolosi renale infetta.
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
WO2001018039A3 (en) INCREASED PRODUCTION OF INTERFERON-$g(a)
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
ITMI913306A1 (it) Composizioni farmaceutiche per la somministrazione nasale di polipeptidi.
IT9021264A0 (it) Composizioni farmaceutiche per la somministrazione intranasale di calcitonina
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.
ITRM920551A1 (it) Composizioni farmaceutiche somministrabili per via intranasale contenenti calcitonina quale principio attivo.
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.